These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28116233)

  • 1. Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.
    Nürnberger L; Gracien RM; Hok P; Hof SM; Rüb U; Steinmetz H; Hilker R; Klein JC; Deichmann R; Baudrexel S
    Neuroimage Clin; 2017; 13():405-414. PubMed ID: 28116233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.
    Gracien RM; Reitz SC; Hof SM; Fleischer V; Droby A; Wahl M; Steinmetz H; Groppa S; Deichmann R; Klein JC
    J Magn Reson Imaging; 2017 Nov; 46(5):1485-1490. PubMed ID: 28240801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.
    Zhang L; Wang M; Sterling NW; Lee EY; Eslinger PJ; Wagner D; Du G; Lewis MM; Truong Y; Bowman FD; Huang X
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):570-580. PubMed ID: 29610105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.
    Klein JC; Rolinski M; Griffanti L; Szewczyk-Krolikowski K; Baig F; Ruffmann C; Groves AR; Menke RAL; Hu MT; Mackay C
    NMR Biomed; 2018 Apr; 31(4):e3900. PubMed ID: 29436039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of brain ageing: a quantitative longitudinal MRI study over 7 years.
    Gracien RM; Nürnberger L; Hok P; Hof SM; Reitz SC; Rüb U; Steinmetz H; Hilker-Roggendorf R; Klein JC; Deichmann R; Baudrexel S
    Eur Radiol; 2017 Apr; 27(4):1568-1576. PubMed ID: 27379992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
    Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
    Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
    Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
    Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
    Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients.
    Lee EY; Sen S; Eslinger PJ; Wagner D; Shaffer ML; Kong L; Lewis MM; Du G; Huang X
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1088-93. PubMed ID: 23932064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical aging - new insights with multiparametric quantitative MRI.
    Seiler A; Schöngrundner S; Stock B; Nöth U; Hattingen E; Steinmetz H; Klein JC; Baudrexel S; Wagner M; Deichmann R; Gracien RM
    Aging (Albany NY); 2020 Aug; 12(16):16195-16210. PubMed ID: 32852283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
    Gracien RM; Reitz SC; Hof SM; Fleischer V; Zimmermann H; Droby A; Steinmetz H; Zipp F; Deichmann R; Klein JC
    Eur Radiol; 2016 Aug; 26(8):2578-86. PubMed ID: 26494641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
    Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2019 Apr; 124():29-35. PubMed ID: 30408592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.